Global Needle-Free Drug Injection Systems Market Research Report 2022

SKU ID : QYR-21348699 | Publishing Date : 18-Jul-2022 | No. of pages : 97

Request a free Sample

Detailed TOC of Global Needle-Free Drug Injection Systems Market Research Report 2022

1 Needle-Free Drug Injection Systems Market Overview
    1.1 Product Overview and Scope of Needle-Free Drug Injection Systems
    1.2 Needle-Free Drug Injection Systems Segment by Type
        1.2.1 Global Needle-Free Drug Injection Systems Sales Growth Rate Comparison by Type (2022-2028)
        1.2.2 Jet-Based Needle-Free Injectors
        1.2.3 Spring-Based Needle-Free Injectors
        1.2.4 Laser-Powered Needle-Free Injectors
        1.2.5 Vibration-Based Needle-Free Injectors
    1.3 Needle-Free Drug Injection Systems Segment by Application
        1.3.1 Global Needle-Free Drug Injection Systems Sales Comparison by Application: (2022-2028)
        1.3.2 Hospitals and Clinics
        1.3.3 Homecare Settings
        1.3.4 Research Laboratories
        1.3.5 Pharmaceutical and Biotechnology companies
        1.3.6 Other End Users
    1.4 Global Needle-Free Drug Injection Systems Market Size Estimates and Forecasts
        1.4.1 Global Needle-Free Drug Injection Systems Revenue 2017-2028
        1.4.2 Global Needle-Free Drug Injection Systems Sales 2017-2028
        1.4.3 Needle-Free Drug Injection Systems Market Size by Region: 2017 Versus 2021 Versus 2028
2 Needle-Free Drug Injection Systems Market Competition by Manufacturers
    2.1 Global Needle-Free Drug Injection Systems Sales Market Share by Manufacturers (2017-2022)
    2.2 Global Needle-Free Drug Injection Systems Revenue Market Share by Manufacturers (2017-2022)
    2.3 Global Needle-Free Drug Injection Systems Average Price by Manufacturers (2017-2022)
    2.4 Manufacturers Needle-Free Drug Injection Systems Manufacturing Sites, Area Served, Product Type
    2.5 Needle-Free Drug Injection Systems Market Competitive Situation and Trends
        2.5.1 Needle-Free Drug Injection Systems Market Concentration Rate
        2.5.2 The Global Top 5 and Top 10 Largest Needle-Free Drug Injection Systems Players Market Share by Revenue
        2.5.3 Global Needle-Free Drug Injection Systems Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Needle-Free Drug Injection Systems Retrospective Market Scenario by Region
    3.1 Global Needle-Free Drug Injection Systems Retrospective Market Scenario in Sales by Region: 2017-2022
    3.2 Global Needle-Free Drug Injection Systems Retrospective Market Scenario in Revenue by Region: 2017-2022
    3.3 North America Needle-Free Drug Injection Systems Market Facts & Figures by Country
        3.3.1 North America Needle-Free Drug Injection Systems Sales by Country
        3.3.2 North America Needle-Free Drug Injection Systems Revenue by Country
        3.3.3 U.S.
        3.3.4 Canada
    3.4 Europe Needle-Free Drug Injection Systems Market Facts & Figures by Country
        3.4.1 Europe Needle-Free Drug Injection Systems Sales by Country
        3.4.2 Europe Needle-Free Drug Injection Systems Revenue by Country
        3.4.3 Germany
        3.4.4 France
        3.4.5 U.K.
        3.4.6 Italy
        3.4.7 Russia
    3.5 Asia Pacific Needle-Free Drug Injection Systems Market Facts & Figures by Region
        3.5.1 Asia Pacific Needle-Free Drug Injection Systems Sales by Region
        3.5.2 Asia Pacific Needle-Free Drug Injection Systems Revenue by Region
        3.5.3 China
        3.5.4 Japan
        3.5.5 South Korea
        3.5.6 India
        3.5.7 Australia
        3.5.8 Taiwan
        3.5.9 Indonesia
        3.5.10 Thailand
        3.5.11 Malaysia
        3.5.12 Philippines
        3.5.13 Vietnam
    3.6 Latin America Needle-Free Drug Injection Systems Market Facts & Figures by Country
        3.6.1 Latin America Needle-Free Drug Injection Systems Sales by Country
        3.6.2 Latin America Needle-Free Drug Injection Systems Revenue by Country
        3.6.3 Mexico
        3.6.4 Brazil
        3.6.5 Argentina
    3.7 Middle East and Africa Needle-Free Drug Injection Systems Market Facts & Figures by Country
        3.7.1 Middle East and Africa Needle-Free Drug Injection Systems Sales by Country
        3.7.2 Middle East and Africa Needle-Free Drug Injection Systems Revenue by Country
        3.7.3 Turkey
        3.7.4 Saudi Arabia
        3.7.5 U.A.E
4 Global Needle-Free Drug Injection Systems Historic Market Analysis by Type
    4.1 Global Needle-Free Drug Injection Systems Sales Market Share by Type (2017-2022)
    4.2 Global Needle-Free Drug Injection Systems Revenue Market Share by Type (2017-2022)
    4.3 Global Needle-Free Drug Injection Systems Price by Type (2017-2022)
5 Global Needle-Free Drug Injection Systems Historic Market Analysis by Application
    5.1 Global Needle-Free Drug Injection Systems Sales Market Share by Application (2017-2022)
    5.2 Global Needle-Free Drug Injection Systems Revenue Market Share by Application (2017-2022)
    5.3 Global Needle-Free Drug Injection Systems Price by Application (2017-2022)
6 Key Companies Profiled
    6.1 Antares Pharma, Inc. (US)
        6.1.1 Antares Pharma, Inc. (US) Corporation Information
        6.1.2 Antares Pharma, Inc. (US) Description and Business Overview
        6.1.3 Antares Pharma, Inc. (US) Needle-Free Drug Injection Systems Sales, Revenue and Gross Margin (2017-2022)
        6.1.4 Antares Pharma, Inc. (US) Needle-Free Drug Injection Systems Product Portfolio
        6.1.5 Antares Pharma, Inc. (US) Recent Developments/Updates
    6.2 Endo International plc (US)
        6.2.1 Endo International plc (US) Corporation Information
        6.2.2 Endo International plc (US) Description and Business Overview
        6.2.3 Endo International plc (US) Needle-Free Drug Injection Systems Sales, Revenue and Gross Margin (2017-2022)
        6.2.4 Endo International plc (US) Needle-Free Drug Injection Systems Product Portfolio
        6.2.5 Endo International plc (US) Recent Developments/Updates
    6.3 PharmaJet (U.S)
        6.3.1 PharmaJet (U.S) Corporation Information
        6.3.2 PharmaJet (U.S) Description and Business Overview
        6.3.3 PharmaJet (U.S) Needle-Free Drug Injection Systems Sales, Revenue and Gross Margin (2017-2022)
        6.3.4 PharmaJet (U.S) Needle-Free Drug Injection Systems Product Portfolio
        6.3.5 PharmaJet (U.S) Recent Developments/Updates
    6.4 Bioject Medical Technologies Inc. (U.S)
        6.4.1 Bioject Medical Technologies Inc. (U.S) Corporation Information
        6.4.2 Bioject Medical Technologies Inc. (U.S) Description and Business Overview
        6.4.3 Bioject Medical Technologies Inc. (U.S) Needle-Free Drug Injection Systems Sales, Revenue and Gross Margin (2017-2022)
        6.4.4 Bioject Medical Technologies Inc. (U.S) Needle-Free Drug Injection Systems Product Portfolio
        6.4.5 Bioject Medical Technologies Inc. (U.S) Recent Developments/Updates
    6.5 Medical International Technology, Inc. (U.S)
        6.5.1 Medical International Technology, Inc. (U.S) Corporation Information
        6.5.2 Medical International Technology, Inc. (U.S) Description and Business Overview
        6.5.3 Medical International Technology, Inc. (U.S) Needle-Free Drug Injection Systems Sales, Revenue and Gross Margin (2017-2022)
        6.5.4 Medical International Technology, Inc. (U.S) Needle-Free Drug Injection Systems Product Portfolio
        6.5.5 Medical International Technology, Inc. (U.S) Recent Developments/Updates
    6.6 INJEX Pharma AG (Germany)
        6.6.1 INJEX Pharma AG (Germany) Corporation Information
        6.6.2 INJEX Pharma AG (Germany) Description and Business Overview
        6.6.3 INJEX Pharma AG (Germany) Needle-Free Drug Injection Systems Sales, Revenue and Gross Margin (2017-2022)
        6.6.4 INJEX Pharma AG (Germany) Needle-Free Drug Injection Systems Product Portfolio
        6.6.5 INJEX Pharma AG (Germany) Recent Developments/Updates
    6.7 National Medical Products Inc. (US)
        6.6.1 National Medical Products Inc. (US) Corporation Information
        6.6.2 National Medical Products Inc. (US) Description and Business Overview
        6.6.3 National Medical Products Inc. (US) Needle-Free Drug Injection Systems Sales, Revenue and Gross Margin (2017-2022)
        6.4.4 National Medical Products Inc. (US) Needle-Free Drug Injection Systems Product Portfolio
        6.7.5 National Medical Products Inc. (US) Recent Developments/Updates
    6.8 Valeritas, Inc. (US)
        6.8.1 Valeritas, Inc. (US) Corporation Information
        6.8.2 Valeritas, Inc. (US) Description and Business Overview
        6.8.3 Valeritas, Inc. (US) Needle-Free Drug Injection Systems Sales, Revenue and Gross Margin (2017-2022)
        6.8.4 Valeritas, Inc. (US) Needle-Free Drug Injection Systems Product Portfolio
        6.8.5 Valeritas, Inc. (US) Recent Developments/Updates
    6.9 European Pharma Group (Netherland)
        6.9.1 European Pharma Group (Netherland) Corporation Information
        6.9.2 European Pharma Group (Netherland) Description and Business Overview
        6.9.3 European Pharma Group (Netherland) Needle-Free Drug Injection Systems Sales, Revenue and Gross Margin (2017-2022)
        6.9.4 European Pharma Group (Netherland) Needle-Free Drug Injection Systems Product Portfolio
        6.9.5 European Pharma Group (Netherland) Recent Developments/Updates
    6.10 PenJet Corporation (U.S)
        6.10.1 PenJet Corporation (U.S) Corporation Information
        6.10.2 PenJet Corporation (U.S) Description and Business Overview
        6.10.3 PenJet Corporation (U.S) Needle-Free Drug Injection Systems Sales, Revenue and Gross Margin (2017-2022)
        6.10.4 PenJet Corporation (U.S) Needle-Free Drug Injection Systems Product Portfolio
        6.10.5 PenJet Corporation (U.S) Recent Developments/Updates
    6.11 Crossject SA (France)
        6.11.1 Crossject SA (France) Corporation Information
        6.11.2 Crossject SA (France) Needle-Free Drug Injection Systems Description and Business Overview
        6.11.3 Crossject SA (France) Needle-Free Drug Injection Systems Sales, Revenue and Gross Margin (2017-2022)
        6.11.4 Crossject SA (France) Needle-Free Drug Injection Systems Product Portfolio
        6.11.5 Crossject SA (France) Recent Developments/Updates
7 Needle-Free Drug Injection Systems Manufacturing Cost Analysis
    7.1 Needle-Free Drug Injection Systems Key Raw Materials Analysis
       7.1.1 Key Raw Materials
       7.1.2 Key Suppliers of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
    7.3 Manufacturing Process Analysis of Needle-Free Drug Injection Systems
    7.4 Needle-Free Drug Injection Systems Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
    8.1 Marketing Channel
    8.2 Needle-Free Drug Injection Systems Distributors List
    8.3 Needle-Free Drug Injection Systems Customers
9 Needle-Free Drug Injection Systems Market Dynamics
    9.1 Needle-Free Drug Injection Systems Industry Trends
    9.2 Needle-Free Drug Injection Systems Market Drivers
    9.3 Needle-Free Drug Injection Systems Market Challenges
    9.4 Needle-Free Drug Injection Systems Market Restraints
10 Global Market Forecast
    10.1 Needle-Free Drug Injection Systems Market Estimates and Projections by Type
        10.1.1 Global Forecasted Sales of Needle-Free Drug Injection Systems by Type (2023-2028)
        10.1.2 Global Forecasted Revenue of Needle-Free Drug Injection Systems by Type (2023-2028)
    10.2 Needle-Free Drug Injection Systems Market Estimates and Projections by Application
        10.2.1 Global Forecasted Sales of Needle-Free Drug Injection Systems by Application (2023-2028)
        10.2.2 Global Forecasted Revenue of Needle-Free Drug Injection Systems by Application (2023-2028)
    10.3 Needle-Free Drug Injection Systems Market Estimates and Projections by Region
        10.3.1 Global Forecasted Sales of Needle-Free Drug Injection Systems by Region (2023-2028)
        10.3.2 Global Forecasted Revenue of Needle-Free Drug Injection Systems by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
    12.1 Methodology/Research Approach
        12.1.1 Research Programs/Design
        12.1.2 Market Size Estimation
        12.1.3 Market Breakdown and Data Triangulation
    12.2 Data Source
        12.2.1 Secondary Sources
        12.2.2 Primary Sources
    12.3 Author List
    12.4 Disclaimer

List of Figures, Tables and Charts Available in Global Needle-Free Drug Injection Systems Market Research Report 2022

List of Tables
    Table 1. Global Needle-Free Drug Injection Systems Sales Growth Rate Comparison by Type (2022-2028) & (K Units) & (US$ Million)
    Table 2. Global Needle-Free Drug Injection Systems Sales Growth Rate Comparison by Application (2022-2028) & (K Units) & (US$ Million)
    Table 3. Global Needle-Free Drug Injection Systems Market Size by Region (US$ Million) (2017 VS 2021 VS 2028)
    Table 4. Global Needle-Free Drug Injection Systems Market Competitive Situation by Manufacturers in 2021
    Table 5. Global Needle-Free Drug Injection Systems Sales (K Units) of Key Manufacturers (2017-2022)
    Table 6. Global Needle-Free Drug Injection Systems Sales Market Share by Manufacturers (2017-2022)
    Table 7. Global Needle-Free Drug Injection Systems Revenue (US$ Million) by Manufacturers (2017-2022)
    Table 8. Global Needle-Free Drug Injection Systems Revenue Share by Manufacturers (2017-2022)
    Table 9. Global Market Needle-Free Drug Injection Systems Average Price (USD/Unit) of Key Manufacturers (2017-2022)
    Table 10. Manufacturers Needle-Free Drug Injection Systems Manufacturing Sites and Area Served
    Table 11. Manufacturers Needle-Free Drug Injection Systems Product Type
    Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 13. Global Needle-Free Drug Injection Systems by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Needle-Free Drug Injection Systems as of 2021)
    Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 15. Global Needle-Free Drug Injection Systems Sales by Region (2017-2022) & (K Units)
    Table 16. Global Needle-Free Drug Injection Systems Sales Market Share by Region (2017-2022)
    Table 17. Global Needle-Free Drug Injection Systems Revenue by Region (2017-2022) & (US$ Million)
    Table 18. Global Needle-Free Drug Injection Systems Revenue Market Share by Region (2017-2022)
    Table 19. North America Needle-Free Drug Injection Systems Sales by Country (2017-2022) & (K Units)
    Table 20. North America Needle-Free Drug Injection Systems Sales Market Share by Country (2017-2022)
    Table 21. North America Needle-Free Drug Injection Systems Revenue by Country (2017-2022) & (US$ Million)
    Table 22. North America Needle-Free Drug Injection Systems Revenue Market Share by Country (2017-2022)
    Table 23. Europe Needle-Free Drug Injection Systems Sales by Country (2017-2022) & (K Units)
    Table 24. Europe Needle-Free Drug Injection Systems Sales Market Share by Country (2017-2022)
    Table 25. Europe Needle-Free Drug Injection Systems Revenue by Country (2017-2022) & (US$ Million)
    Table 26. Europe Needle-Free Drug Injection Systems Revenue Market Share by Country (2017-2022)
    Table 27. Asia Pacific Needle-Free Drug Injection Systems Sales by Region (2017-2022) & (K Units)
    Table 28. Asia Pacific Needle-Free Drug Injection Systems Sales Market Share by Region (2017-2022)
    Table 29. Asia Pacific Needle-Free Drug Injection Systems Revenue by Region (2017-2022) & (US$ Million)
    Table 30. Asia Pacific Needle-Free Drug Injection Systems Revenue Market Share by Region (2017-2022)
    Table 31. Latin America Needle-Free Drug Injection Systems Sales by Country (2017-2022) & (K Units)
    Table 32. Latin America Needle-Free Drug Injection Systems Sales Market Share by Country (2017-2022)
    Table 33. Latin America Needle-Free Drug Injection Systems Revenue by Country (2017-2022) & (US$ Million)
    Table 34. Latin America Needle-Free Drug Injection Systems Revenue Market Share by Country (2017-2022)
    Table 35. Middle East and Africa Needle-Free Drug Injection Systems Sales by Country (2017-2022) & (K Units)
    Table 36. Middle East and Africa Needle-Free Drug Injection Systems Sales Market Share by Country (2017-2022)
    Table 37. Middle East and Africa Needle-Free Drug Injection Systems Revenue by Country (2017-2022) & (US$ Million)
    Table 38. Middle East and Africa Needle-Free Drug Injection Systems Revenue Market Share by Country (2017-2022)
    Table 39. Global Needle-Free Drug Injection Systems Sales by Type (2017-2022) & (K Units)
    Table 40. Global Needle-Free Drug Injection Systems Sales Market Share by Type (2017-2022)
    Table 41. Global Needle-Free Drug Injection Systems Revenue by Type (2017-2022) & (US$ Million)
    Table 42. Global Needle-Free Drug Injection Systems Revenue Share by Type (2017-2022)
    Table 43. Global Needle-Free Drug Injection Systems Price by Type (2017-2022) & (USD/Unit)
    Table 44. Global Needle-Free Drug Injection Systems Sales (K Units) by Application (2017-2022)
    Table 45. Global Needle-Free Drug Injection Systems Sales Market Share by Application (2017-2022)
    Table 46. Global Needle-Free Drug Injection Systems Revenue by Application (2017-2022) & (US$ Million)
    Table 47. Global Needle-Free Drug Injection Systems Revenue Share by Application (2017-2022)
    Table 48. Global Needle-Free Drug Injection Systems Price by Application (2017-2022) & (USD/Unit)
    Table 49. Antares Pharma, Inc. (US) Corporation Information
    Table 50. Antares Pharma, Inc. (US) Description and Business Overview
    Table 51. Antares Pharma, Inc. (US) Needle-Free Drug Injection Systems Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 52. Antares Pharma, Inc. (US) Needle-Free Drug Injection Systems Product
    Table 53. Antares Pharma, Inc. (US) Recent Developments/Updates
    Table 54. Endo International plc (US) Corporation Information
    Table 55. Endo International plc (US) Description and Business Overview
    Table 56. Endo International plc (US) Needle-Free Drug Injection Systems Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 57. Endo International plc (US) Needle-Free Drug Injection Systems Product
    Table 58. Endo International plc (US) Recent Developments/Updates
    Table 59. PharmaJet (U.S) Corporation Information
    Table 60. PharmaJet (U.S) Description and Business Overview
    Table 61. PharmaJet (U.S) Needle-Free Drug Injection Systems Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 62. PharmaJet (U.S) Needle-Free Drug Injection Systems Product
    Table 63. PharmaJet (U.S) Recent Developments/Updates
    Table 64. Bioject Medical Technologies Inc. (U.S) Corporation Information
    Table 65. Bioject Medical Technologies Inc. (U.S) Description and Business Overview
    Table 66. Bioject Medical Technologies Inc. (U.S) Needle-Free Drug Injection Systems Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 67. Bioject Medical Technologies Inc. (U.S) Needle-Free Drug Injection Systems Product
    Table 68. Bioject Medical Technologies Inc. (U.S) Recent Developments/Updates
    Table 69. Medical International Technology, Inc. (U.S) Corporation Information
    Table 70. Medical International Technology, Inc. (U.S) Description and Business Overview
    Table 71. Medical International Technology, Inc. (U.S) Needle-Free Drug Injection Systems Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 72. Medical International Technology, Inc. (U.S) Needle-Free Drug Injection Systems Product
    Table 73. Medical International Technology, Inc. (U.S) Recent Developments/Updates
    Table 74. INJEX Pharma AG (Germany) Corporation Information
    Table 75. INJEX Pharma AG (Germany) Description and Business Overview
    Table 76. INJEX Pharma AG (Germany) Needle-Free Drug Injection Systems Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 77. INJEX Pharma AG (Germany) Needle-Free Drug Injection Systems Product
    Table 78. INJEX Pharma AG (Germany) Recent Developments/Updates
    Table 79. National Medical Products Inc. (US) Corporation Information
    Table 80. National Medical Products Inc. (US) Description and Business Overview
    Table 81. National Medical Products Inc. (US) Needle-Free Drug Injection Systems Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 82. National Medical Products Inc. (US) Needle-Free Drug Injection Systems Product
    Table 83. National Medical Products Inc. (US) Recent Developments/Updates
    Table 84. Valeritas, Inc. (US) Corporation Information
    Table 85. Valeritas, Inc. (US) Description and Business Overview
    Table 86. Valeritas, Inc. (US) Needle-Free Drug Injection Systems Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 87. Valeritas, Inc. (US) Needle-Free Drug Injection Systems Product
    Table 88. Valeritas, Inc. (US) Recent Developments/Updates
    Table 89. European Pharma Group (Netherland) Corporation Information
    Table 90. European Pharma Group (Netherland) Description and Business Overview
    Table 91. European Pharma Group (Netherland) Needle-Free Drug Injection Systems Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 92. European Pharma Group (Netherland) Needle-Free Drug Injection Systems Product
    Table 93. European Pharma Group (Netherland) Recent Developments/Updates
    Table 94. PenJet Corporation (U.S) Corporation Information
    Table 95. PenJet Corporation (U.S) Description and Business Overview
    Table 96. PenJet Corporation (U.S) Needle-Free Drug Injection Systems Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 97. PenJet Corporation (U.S) Needle-Free Drug Injection Systems Product
    Table 98. PenJet Corporation (U.S) Recent Developments/Updates
    Table 99. Crossject SA (France) Corporation Information
    Table 100. Crossject SA (France) Description and Business Overview
    Table 101. Crossject SA (France) Needle-Free Drug Injection Systems Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 102. Crossject SA (France) Needle-Free Drug Injection Systems Product
    Table 103. Crossject SA (France) Recent Developments/Updates
    Table 104. Production Base and Market Concentration Rate of Raw Material
    Table 105. Key Suppliers of Raw Materials
    Table 106. Needle-Free Drug Injection Systems Distributors List
    Table 107. Needle-Free Drug Injection Systems Customers List
    Table 108. Needle-Free Drug Injection Systems Market Trends
    Table 109. Needle-Free Drug Injection Systems Market Drivers
    Table 110. Needle-Free Drug Injection Systems Market Challenges
    Table 111. Needle-Free Drug Injection Systems Market Restraints
    Table 112. Global Needle-Free Drug Injection Systems Sales Forecast by Type (2023-2028) & (K Units)
    Table 113. Global Needle-Free Drug Injection Systems Sales Market Share Forecast by Type (2023-2028)
    Table 114. Global Needle-Free Drug Injection Systems Revenue Forecast by Type (2023-2028) & (US$ Million)
    Table 115. Global Needle-Free Drug Injection Systems Revenue Market Share Forecast by Type (2023-2028)
    Table 116. Global Needle-Free Drug Injection Systems Sales Forecast by Application (2023-2028) & (K Units)
    Table 117. Global Needle-Free Drug Injection Systems Sales Market Share Forecast by Application (2023-2028)
    Table 118. Global Needle-Free Drug Injection Systems Revenue Forecast by Application (2023-2028) & (US$ Million)
    Table 119. Global Needle-Free Drug Injection Systems Revenue Market Share Forecast by Application (2023-2028)
    Table 120. Global Needle-Free Drug Injection Systems Sales Forecast by Region (2023-2028) & (K Units)
    Table 121. Global Needle-Free Drug Injection Systems Sales Market Share Forecast by Region (2023-2028)
    Table 122. Global Needle-Free Drug Injection Systems Revenue Forecast by Region (2023-2028) & (US$ Million)
    Table 123. Global Needle-Free Drug Injection Systems Revenue Market Share Forecast by Region (2023-2028)
    Table 124. Research Programs/Design for This Report
    Table 125. Key Data Information from Secondary Sources
    Table 126. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of Needle-Free Drug Injection Systems
    Figure 2. Global Needle-Free Drug Injection Systems Market Share by Type in 2021 & 2028
    Figure 3. Jet-Based Needle-Free Injectors Product Picture
    Figure 4. Spring-Based Needle-Free Injectors Product Picture
    Figure 5. Laser-Powered Needle-Free Injectors Product Picture
    Figure 6. Vibration-Based Needle-Free Injectors Product Picture
    Figure 7. Global Needle-Free Drug Injection Systems Market Share by Application in 2021 & 2028
    Figure 8. Hospitals and Clinics
    Figure 9. Homecare Settings
    Figure 10. Research Laboratories
    Figure 11. Pharmaceutical and Biotechnology companies
    Figure 12. Other End Users
    Figure 13. Global Needle-Free Drug Injection Systems Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 14. Global Needle-Free Drug Injection Systems Market Size (2017-2028) & (US$ Million)
    Figure 15. Global Needle-Free Drug Injection Systems Sales (2017-2028) & (K Units)
    Figure 16. Needle-Free Drug Injection Systems Sales Share by Manufacturers in 2021
    Figure 17. Global Needle-Free Drug Injection Systems Revenue Share by Manufacturers in 2021
    Figure 18. The Global 5 and 10 Largest Needle-Free Drug Injection Systems Players: Market Share by Revenue in 2021
    Figure 19. Needle-Free Drug Injection Systems Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
    Figure 20. Global Needle-Free Drug Injection Systems Sales Market Share by Region (2017-2022)
    Figure 21. Global Needle-Free Drug Injection Systems Sales Market Share by Region in 2021
    Figure 22. Global Needle-Free Drug Injection Systems Revenue Market Share by Region (2017-2022)
    Figure 23. Global Needle-Free Drug Injection Systems Revenue Market Share by Region in 2021
    Figure 24. U.S. Needle-Free Drug Injection Systems Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 25. Canada Needle-Free Drug Injection Systems Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 26. Germany Needle-Free Drug Injection Systems Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 27. France Needle-Free Drug Injection Systems Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 28. U.K. Needle-Free Drug Injection Systems Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 29. Italy Needle-Free Drug Injection Systems Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 30. Russia Needle-Free Drug Injection Systems Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 31. China Needle-Free Drug Injection Systems Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 32. Japan Needle-Free Drug Injection Systems Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 33. South Korea Needle-Free Drug Injection Systems Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 34. India Needle-Free Drug Injection Systems Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 35. Australia Needle-Free Drug Injection Systems Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 36. Taiwan Needle-Free Drug Injection Systems Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 37. Indonesia Needle-Free Drug Injection Systems Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 38. Thailand Needle-Free Drug Injection Systems Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 39. Malaysia Needle-Free Drug Injection Systems Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 40. Philippines Needle-Free Drug Injection Systems Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 41. Vietnam Needle-Free Drug Injection Systems Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 42. Mexico Needle-Free Drug Injection Systems Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 43. Brazil Needle-Free Drug Injection Systems Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 44. Argentina Needle-Free Drug Injection Systems Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 45. Turkey Needle-Free Drug Injection Systems Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 46. Saudi Arabia Needle-Free Drug Injection Systems Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 47. U.A.E Needle-Free Drug Injection Systems Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 48. Sales Market Share of Needle-Free Drug Injection Systems by Type (2017-2022)
    Figure 49. Manufacturing Cost Structure of Needle-Free Drug Injection Systems
    Figure 50. Manufacturing Process Analysis of Needle-Free Drug Injection Systems
    Figure 51. Needle-Free Drug Injection Systems Industrial Chain Analysis
    Figure 52. Channels of Distribution
    Figure 53. Distributors Profiles
    Figure 54. Bottom-up and Top-down Approaches for This Report
    Figure 55. Data Triangulation
    Figure 56. Key Executives Interviewed

Keyplayers in Global Needle-Free Drug Injection Systems Market Research Report 2022

Antares Pharma, Inc. (US)
Endo International plc (US)
PharmaJet (U.S)
Bioject Medical Technologies Inc. (U.S)
Medical International Technology, Inc. (U.S)
INJEX Pharma AG (Germany)
National Medical Products Inc. (US)
Valeritas, Inc. (US)
European Pharma Group (Netherland)
PenJet Corporation (U.S)
Crossject SA (France)